533-35-7 Usage
Uses
Used in Pharmaceutical Industry:
6,7-dihydro-5H-2-pyrindine serves as a crucial building block in organic synthesis, utilized for the development of new pharmaceuticals. Its unique structure allows it to be a key component in the creation of various medicinal compounds.
Used in Medicinal Chemistry Research:
As a heterocyclic compound, 6,7-dihydro-5H-2-pyrindine is used in medicinal chemistry research to explore its potential pharmacological activities. 6,7-dihydro-5H-2-pyrindine's ability to be modified and incorporated into different molecular structures makes it a versatile candidate for investigating its effects on various biological targets.
Used in Drug Development:
6,7-dihydro-5H-2-pyrindine is employed in drug development for its potential therapeutic properties. Its unique structure and potential to exhibit pharmacological activities position it as a promising candidate for the development of new drugs targeting a range of health conditions.
Overall, 6,7-dihydro-5H-2-pyrindine is a significant compound in the fields of pharmaceuticals, medicinal chemistry, and drug development due to its potential applications and the opportunities it presents for further research and innovation.
Check Digit Verification of cas no
The CAS Registry Mumber 533-35-7 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,3 and 3 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 533-35:
(5*5)+(4*3)+(3*3)+(2*3)+(1*5)=57
57 % 10 = 7
So 533-35-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H9N/c1-2-7-4-5-9-6-8(7)3-1/h4-6H,1-3H2
533-35-7Relevant academic research and scientific papers
Synthesis of hexahydro-2-pyrindine (=hexahydrocyclopenta[c]pyridine) derivatives as conformationally restricted analogs of the nicotinic ligands arecolone and isoarecolone
Guandalini, Luca,Dei, Silvia,Gualtieri, Fulvio,Romanelli, Maria Novella,Scapecchi, Serena,Teodori, Elisabetta,Varani, Katia
, p. 96 - 107 (2007/10/03)
Two hexahydropyrindine derivatives, 1,2,3,4,6,7-hexahydro-2-methyl-5H-cyclopenta[c]pyridin-5-one (1) and 1,2,3,4,5,6-hexahydro-2-methyl-7H-cyclopenta[c]pyridin-7-one (2), and their methiodides 14 and 26, respectively, were synthesized. They can be considered rigid analogues of the known nicotinic agonists arecolone (=1-(1,2,5,6-tetrahydro-1-methylpyridin-3-yl)ethanone) and isoarecolone (=1-(1,2,3,6-tetrahydro-1-methylpyridin-4-yl)ethanone). The affinity for the central nicotinic receptor were measured on rat cerebral cortex. Although only the methiodide 14, among the four conformationally restricted compounds, shows an appreciable affinity, the results obtained provide useful information on the molecular requirements at the interaction site of the central nicotinic receptors.
